3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
70
Triple Negative Breast Neoplasms
5
Carcinoma, Intraductal, Noninfiltrating
4
Inflammatory Breast Neoplasms
3
Seroma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Invasive Breast Cancer
2
Carcinoma, Ductal, Breast
2
Breast Cancer Invasive
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Premenopausal Breast Cancer
1
Patient Preference
1
Pain, Postoperative
1
Pain
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Myofibroma
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Inflammation
1
Hereditary Breast and Ovarian Cancer Syndrome
1
HER2-positive Early Breast Cancer
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
pertuzumab
1
Trastuzumab
1
Surgical Procedures, Operative
1
Radiotherapy
1
Injections, Subcutaneous
1
Focus Groups
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Preference
×
Surgical Procedures, Operative
×
Breast
×
Clear all
NCT05415215
2026-02-10
ProHer
Hoffmann-La Roche
Phase 3
Completed
346 enrolled
20 charts